BMP-2YBased repair of large-scale calvarial defects in an experimental model: regenerative surgery in cranioplasty

Journal of Craniofacial Surgery

Volumn 19, Issue 5, 2008, Pages 1315-1322

  Smith, Darren M ^a   Afifi, Ahmed M ^a   Cooper, Gregory M ^a   Mooney, Mark P ^a   Marra, Kacey G ^a   Losee, Joseph E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

BMP; Calvarial defect; Cranial reconstruction; Pediatric

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN SPONGE; BONE MORPHOGENETIC PROTEIN; COLLAGEN; GELATIN SPONGE; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE RADIOGRAPHY; CALVARIAL DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRANIOPLASTY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SKULL DEFECT; ANIMAL; BONE REGENERATION; CRANIOTOMY; DRUG EFFECT; HUMAN; MICRO-COMPUTED TOMOGRAPHY; RABBIT; SKULL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; COLLAGEN; CRANIOTOMY; GELATIN SPONGE, ABSORBABLE; HUMANS; MODELS, ANIMAL; RABBITS; RECOMBINANT PROTEINS; SKULL; TRANSFORMING GROWTH FACTOR BETA; X-RAY MICROTOMOGRAPHY;

EID: 58249088291     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181843369     Document Type: Article

References (55)

1. Cho YR, Gosain AK. Biomaterials in craniofacial reconstruction. Clin Plast Surg 2004;31:377Y385
2. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560Y567
3. Arnaud E, De Pollak C, Meunier A, et al. Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty. Biomaterials 1999;20:1909Y1918
4. Dudas JR, Marra KG, Cooper GM, et al. The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects. Ann Plast Surg 2006;56:543Y548
5. Cowan CM, Aalami OO, Shi YY, et al. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 2005;11:645Y658
6. Sato K, Urist MR. Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res 1985;301Y311
7. Marden LJ, Hollinger JO, Chaudhari A, et al. Recombinant human bone morphogenetic protein-2 is superior to deminer-alized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 1994;28:1127Y1138
8. Sheehan JP, Sheehan JM, Seeherman H, et al. The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. J Neurosurg 2003;98:125Y130
9. Lindholm TC, Lindholm TS, Marttinen A, et al. Bovine bone morphogenetic protein (bBMP/NCP)-induced repair of skull trephine defects in pigs. Clin Orthop Relat Res 1994; 263Y270
10. Ferguson D, Davis WL, Urist MR, et al. Bovine bone morphogenetic protein (bBMP) fraction-induced repair of craniotomy defects in the rhesus monkey (Macaca speciosa). Clin Orthop Relat Res 1987;251Y258
11. Hollinger J, Mark DE, Bach DE, et al. Calvarial bone regeneration using osteogenin. J Oral Maxillofac Surg 1989; 47:1182Y1186; discussion 1187
12. Ripamonti U, Ma SS, van den Heever B, et al. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydro-xyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg 1992;90:382Y393
13. Springer IN, Acil Y, Kuchenbecker S, et al. Bone graft versus BMP-7 in a critical size defectVcranioplasty in a growing infant model. Bone 2005;37:563Y569
14. Urist MR. Bone: formation by autoinduction. Science 1965; 150:893Y899
15. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843Y9847
16. Wozney JM, Rosen V, Byrne M, et al. Growth factors influencing bone development. J Cell Sci Suppl 1990;13:149Y156
17. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528Y1534
18. Ripamonti U. The generation of bone in primates by bone morphogenetic proteins. In: Lindholm TS, ed. Bone Morphogenetic Proteins: Biology, Biochemistry and Reconstructive Surgery. Austin, TX: RG Landes Co, 1996
19. Sampath KT. Bone morphogenetic proteins and their role in regenerative medicine. In: Vukicevic S, Sampath KT, eds. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond. Basel, Switzerland: Birkhauser Verlag, 2004:1Y8
20. De Biase P, Capanna R. Clinical applications of BMPs. Injury 2005;36:S43YS46
21. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004;11:1312Y1320
22. Sarras MP Jr. BMP-1 and the astacin family of metalloprotei- nases: a potential link between the extracellular matrix, growth factors and pattern formation. Bioessays 1996;18:439Y442
23. Rosen V. BMP and BMP inhibitors in bone. Ann N Y Acad Sci 2006;1068:19Y25
24. Wutzl A, Brozek W, Lernbass I, et al. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A 2006;77:75Y83
25. Baskin DS, Ryan P, Sonntag V, et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allo-graft ring and the ATLANTIS anterior cervical plate. Spine 2003;28:1219Y1225; discussion 1225
26. Villavicencio AT, Burneikiene S, Nelson EL, et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine 2005;3:436Y443
27. Haid RW Jr, Branch CL Jr, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527Y538; discussion 538-529
28. McKay WF, Peckham SM, Marotta JS. The Science of rhBMP-2. St Louis, MO: Quality Medical Publishing Inc, 2006.
29. FDA. Spine indication letter. Available at: http://www.fda.gov/cdrh/pdf/ P000058a.pdf. Accessed January 7, 2008
30. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A:2123Y2134
31. FDA. Tibia indication letter. Available at: http://www.fda.gov/cdrh/PDF4/ p000054a.pdf. Accessed January 7, 2008
32. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg2005;63:1693Y1707
33. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:11Y25
34. FDA. Dental indication letter. Available at: http://www.fda.gov/cdrh/ pdf5/p050053a.pdf. Accessed January 7,2008
35. Mooney MP, Siegel MI. Animal models for bone tissue engineering of critical-sized defects (CSDs), bone pathologies, and orthopedic disease states. In: Hollinger JO, Einhorn TA, Doll BA, et al, eds. Fundamentals of Bone Tissue Engineering. Boca Raton, FL: CRC Press, 2005:217Y244
36. Poisson E, Sciote JJ, Koepsel R, et al. Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac J 2004;41:392Y402
37. Arnander C, Westermark A, Veltheim R, et al. Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction. J Craniofac Surg 2006;17:275Y279
38. Carstens MH, Chin M, Ng T, et al. Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg 2005;16:1023Y1032
39. Chao M, Donovan T, Sotelo C, et al. In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduc-tion via stem cell concentration. J Craniofac Surg 2006;17:405Y412
40. Chin M, Carstens MH. Distraction osteogenesis with bone morphogenetic protein enhancement: facial cleft repair in humans. Proceedings of the 4th International Congress on Cranial and Facial Distraction Processes, Paris, France, 2003
41. Chin M, Ng T, Tom WK, et al. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg 2005;16:778Y789
42. Cochran DL, Jones AA, Lilly LC, et al. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000;71:1241Y1257
43. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003;55: 1613Y1629
44. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:124Y139
45. Carstens M. Clinical applications of recombinant human bone morphogenetic protein in craniofacial surgery. In: International Society of Craniofacial Surgery: Biennial International Conference, Bahia, Brazil, 2007.
46. Podda S, Wolfe SA. Switch cranioplasty and BMP-2 in a hemicranial reconstruction in an infant. In: International Society of Craniofacial Surgery: Biennial International Conference, Bahia, Brazil, 2007
47. White KK, Bawa M, Ahn JS, et al. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model. Spine 2005;30:1386Y1395
48. Minamide A, Tamaki T, Kawakami M, et al. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Spine 1999;24:1863Y1870; discussion 1871Y1862
49. Luppen CA, Blake CA, Ammirati KM, et al. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits. J Bone Miner Res 2002;17:301Y310
50. Welch RD, Jones AL, Bucholz RW, et al. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 1998;13:1483Y1490
51. Takahashi Y, Yamamoto M, Yamada K, et al. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2007;13:293Y300
52. Bradley J. Panel 2: bone morphogenetic proteins. In: International Society of Craniofacial Surgery: Biennial International Conference, Bahia, Brazil, 2007
53. Carstens M. Panel 2: bone morphogenetic proteins. In: International Society of Craniofacial Surgery: Biennial International Conference, Bahia, Brazil, 2007
54. Seeherman H, Li R, Wozney J. A review of preclinical program development for evaluating injectable carriers for osteogenic factors. J Bone Joint Surg Am 2003;85-A(suppl 3):96Y108
55. Yoon ST, Boden SD. Osteoinductive molecules in orthopaedics: basic science and preclinical studies. Clin Orthop Relat Res 2002;33Y43